Psoriasis and tuberculosis (TB) are 2 conditions with high prevalence in the general population, often present simultaneously in the same patient. The crucial cytokine involved in the pathogenesis of psoriasis, tumor necrosis factor alpha (TNF-alpha), also is important in defending against mycobacteria. Therefore, it is important to screen patients for a latent TB infection (LTBI) while they are undergoing treatment with TNF-alpha antagonists. We present a case of a patient with psoriasis and LTBI who underwent treatment with etanercept.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
severe psoriasis
4
psoriasis positive
4
positive tuberculosis
4
tuberculosis test
4
test treatment
4
treatment biologic
4
biologic therapy
4
therapy case
4
case report
4
report psoriasis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!